Needle-free vaccine delivery

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Expert Opinion on Drug Delivery

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/17425247.4.5.459PMID 17880271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary vaccine delivery

  2007cited by this paper
• Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile.

  2007cited by this paper
• Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.

  2007cited by this paper
• Coated microneedles for transdermal delivery.

  2007cited by this paper
• Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans

  2007cited by this paper
• Rotarix™ (RIX4414): an oral human rotavirus vaccine

  2007cited by this paper
• Vivotif® – A ‘Magic Shield’ for Protection against Typhoid Fever and Delivery of Heterologous Antigens

  2007cited by this paper
• The Bacterial Second Messenger cdiGMP Exhibits Promising Activity as a Mucosal Adjuvant

  2007cited by this paper
• Active induction of tumor-specific IgE antibodies by oral mimotope vaccination.

  2007cited by this paper
• Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.

  2007cited by this paper
• Hepatitis-B surface antigen (HBsAg) powder formulation: process and stability assessment.

  2007cited by this paper
• Safety and Immunogenicity of an Enterotoxigenic Escherichia coli Vaccine Patch Containing Heat-Labile Toxin: Use of Skin Pretreatment To Disrupt the Stratum Corneum

  2007cited by this paper
• Live attenuated versus inactivated influenza vaccine in infants and young children.

  2007cited by this paper
• Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs.

  2007cited by this paper
• Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model.

  2007cited by this paper
• Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin.

  2007cited by this paper
• Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.

  2007cited by this paper
• Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72.

  2007cited by this paper
• N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.

  2007cited by this paper
• Optimization of a jet‐propelled particle injection system for the uniform transdermal delivery of drug/vaccine

  2007cited by this paper
• Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine.

  2007cited by this paper
• The use of breast-feeding for pain relief during neonatal immunization injections.

  2007cited by this paper
• Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?

  2007cited by this paper
• Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.

  2007cited by this paper
• Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine.

  2007cited by this paper
• Antibody responses after dose-sparing intradermal influenza vaccination.

  2007cited by this paper
• Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections

  2007cited by this paper
• Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets

  2007cited by this paper
• Trivalent Vaccine against Botulinum Toxin Serotypes A, B, and E That Can Be Administered by the Mucosal Route

  2007cited by this paper
• Candidate Live, Attenuated Salmonella enterica Serotype Typhimurium Vaccines with Reduced Fecal Shedding Are Immunogenic and Effective Oral Vaccines

  2007cited by this paper
• Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.

  2007cited by this paper
• Topical/mucosal delivery of sub-unit vaccines that stimulate the ocular mucosal immune system.

  2006cited by this paper
• Safety and Immunogenicity of an Oral Inactivated Whole-Cell Pseudomonas aeruginosa Vaccine Administered to Healthy Human Subjects

  2006cited by this paper
• Mucosal vaccines: the promise and the challenge

  2006cited by this paper
• Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant.

  2006cited by this paper
• Transdermal protein delivery by a coadministered peptide identified via phage display

  2006cited by this paper
• Intranasal Immunization with the Cholera Toxin B Subunit-Pneumococcal Surface Antigen A Fusion Protein Induces Protection against Colonization with Streptococcus pneumoniae and Has Negligible Impact on the Nasopharyngeal and Oral Microbiota of Mice

  2006cited by this paper
• Dendritic Cell-Mediated Induction of Mucosal Cytotoxic Responses following Intravaginal Immunization with the Nontoxic B Subunit of Cholera Toxin1

  2006cited by this paper
• A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2.

  2006cited by this paper
• Live Attenuated B. pertussis as a Single-Dose Nasal Vaccine against Whooping Cough

  2006cited by this paper
• Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.

  2006cited by this paper
• Mucosal Adjuvant Properties of the Shigella Invasin Complex

  2006cited by this paper
• Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers

  2006cited by this paper
• Current status and future prospects of needle-free liquid jet injectors

  2006cited by this paper
• Microneedle-Based Intradermal Delivery of the Anthrax Recombinant Protective Antigen Vaccine

  2006cited by this paper
• Biosafety evaluation of recombinant live oral bacterial vaccines in the context of European regulation.

  2006cited by this paper
• Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge

  2006cited by this paper
• Use of an oral diphtheria vaccine in human.

  2006cited by this paper
• Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groups.

  2006cited by this paper
• Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects.

  2006cited by this paper
• Perspectives on polio and immunization in Northern Nigeria.

  2006influential reference
• Novel approaches to pediatric vaccine delivery.

  2006cited by this paper
• Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.

  2006cited by this paper
• Mucosal delivery of vaccine antigens and its advantages in pediatrics.

  2006cited by this paper
• Elastic liposomes mediated transcutaneous immunization against Hepatitis B.

  2006cited by this paper
• The MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication?

  2006cited by this paper
• Comparison of the Efficacy and Safety of Live Attenuated Cold-Adapted Influenza Vaccine, Trivalent, With Trivalent Inactivated Influenza Virus Vaccine in Children and Adolescents With Asthma

  2006cited by this paper
• Topical DNA vaccination with DNA/Lipid based complex.

  2006cited by this paper
• Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral

  2006cited by this paper
• Nasal Immunization with Anthrax Protective Antigen Protein Adjuvanted with Polyriboinosinic–Polyribocytidylic Acid Induced Strong Mucosal and Systemic Immunities

  2006cited by this paper
• Intranasal Vaccination with Recombinant Outer Membrane Protein CD and Adamantylamide Dipeptide as the Mucosal Adjuvant Enhances Pulmonary Clearance of Moraxella catarrhalis in an Experimental Murine Model

  2006cited by this paper
• Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system.

  2006cited by this paper
• Regulation of Production of Mucosal Antibody to Pneumococcal Protein Antigens by T-Cell-Derived Gamma Interferon and Interleukin-10 in Children

  2006cited by this paper
• Intranasal lipopeptide primes lung‐resident memory CD8+ T cells for long‐term pulmonary protection against influenza

  2006cited by this paper
• Modified Pulmonary Surfactant Is a Potent Adjuvant That Stimulates the Mucosal IgA Production in Response to the Influenza Virus Antigen1

  2006cited by this paper
• Needle-free liquid jet injections: mechanisms and applications

  2006cited by this paper
• Intrarectal Immunization with Rotavirus 2/6 Virus-Like Particles Induces an Antirotavirus Immune Response Localized in the Intestinal Mucosa and Protects against Rotavirus Infection in Mice

  2006cited by this paper
• Crude saponins improve the immune response to an oral plant-made measles vaccine.

  2006cited by this paper
• Live attenuated oral cholera vaccines

  2006cited by this paper
• A Bacterial Flagellin, Vibrio vulnificus FlaB, Has a Strong Mucosal Adjuvant Activity To Induce Protective Immunity

  2006cited by this paper
• A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations.

  2006cited by this paper
• B subunit of E. coli enterotoxin as adjuvant and carrier in oral and skin vaccination.

  2006cited by this paper
• Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization.

  2006cited by this paper
• Vaginal Protection and Immunity after Oral Immunization of Mice with a Novel Vaccine Strain of Listeria monocytogenes Expressing Human Immunodeficiency Virus Type 1 gag

  2006cited by this paper
• Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam.

  2006cited by this paper
• Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

  2006cited by this paper
• Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens1

  2006cited by this paper
• Vaccine delivery--current trends and future.

  2006cited by this paper
• The HIV-1 matrix protein p17 can be efficiently delivered by intranasal route in mice using the TLR 2/6 agonist MALP-2 as mucosal adjuvant.

  2006cited by this paper
• Alternative routes of influenza vaccine delivery

  2006cited by this paper
• Delivery systems and adjuvants for oral vaccines

  2006cited by this paper
• Construction and Phase I Clinical Evaluation of the Safety and Immunogenicity of a Candidate Enterotoxigenic Escherichia coli Vaccine Strain Expressing Colonization Factor Antigen CFA/I

  2006cited by this paper
• Mucosal Immunization with Surface-Displayed Severe Acute Respiratory Syndrome Coronavirus Spike Protein on Lactobacillus casei Induces Neutralizing Antibodies in Mice

  2006cited by this paper
• Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant.

  2006cited by this paper
• Transfersomes for transdermal drug delivery

  2006cited by this paper
• Mass vaccination: solutions in the skin.

  2006cited by this paper
• Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.

  2006cited by this paper
• Needle-free vaccine delivery.

  2006cited by this paper
• Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations

  2006cited by this paper
• The role of adjuvants in the development of mucosal vaccines

  2005cited by this paper
• The advantage of mucosal immunization for polysaccharide‐specific memory responses in early life

  2005cited by this paper
• Microneedles coated with porous calcium phosphate ceramics: Effective vehicles for transdermal delivery of solid trehalose

  2005cited by this paper
• Mucosal immunity and vaccines

  2005cited by this paper
• Immunogenicity in humans of an edible vaccine for hepatitis B.

  2005cited by this paper
• In Vitro and In Vivo Characterization of MEMS Microneedles

  2005cited by this paper
• Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.

  2005cited by this paper
• Low-frequency ultrasound as a transcutaneous immunization adjuvant.

  2005cited by this paper
• A Non-Living Nasal Influenza Vaccine Can Induce Major Humoral and Cellular Immune Responses in Humans without the Need for Adjuvants

  2005cited by this paper
• Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.

  2005cited by this paper
• Immunization without needles

  2005cited by this paper

• Influenza hemagglutinin and neuraminidase multivalent vaccine elicits broader protective immune responses compared to vaccine formulations composed of hemagglutinin or neuraminidase

  2025cites this paper
• Needle-free injection device for administration of cloprostenol to induce luteolysis in lactating dairy cows

  2025cites this paper
• Beyond the Needle: Innovative Microneedle-Based Transdermal Vaccination

  2025cites this paper
• Micro-needle jet injection technology for tunable drug dispersion at delivery

  2025cites this paper
• A detailed review of the recent development of needle-free drug delivery devices

  2025cites this paper
• Probiotic-based oral vaccine mucosal delivery system enabling genetically encoded dual-antigen arrays

  2025cites this paper
• mRNA vaccine platforms and novel delivery systems: From mechanistic principles to clinical translation

  2025cites this paper
• Optimal standoff distance for a highly focused microjet penetrating a soft material

  2024cites this paper
• Advancements in microneedle technology: current status and next-generation innovations

  2024cites this paper
• Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic viruses

  2024cites this paper
• A Needle-Free Shock Syringe for Drug Delivery into Skin

  2024cites this paper
• Unravelling the role of microneedles in drug delivery: Principle, perspectives, and practices

  2023cites this paper
• A comprehensive review of nanosuspension loaded microneedles: fabrication methods, applications, and recent developments

  2023cites this paper
• The effects of cavitation position on the velocity of a laser-induced microjet extracted using explainable artificial intelligence

  2023cites this paper
• Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles

  2023cites this paper
• Silk Fibroin Microneedles for Transdermal Drug Delivery: Where Do We Stand and How Far Can We Proceed?

  2023cites this paper
• Bubble dynamics and speed of jets for needle-free injections produced by thermocavitation

  2023cites this paper
• Non-Inferiority Field Study Comparing the Administrations by Conventional Needle-Syringe and Needle-Free Injectors of a Trivalent Vaccine Containing Porcine Circovirus Types 2a/2b and Mycoplasma hyopneumoniae

  2022cites this paper
• Nasal vaccine as a booster shot: a viable solution to restrict pandemic?

  2022cites this paper
• Aerosolizable Plasmid DNA Dry Powders Engineered by Thin-film Freezing

  2022cites this paper
• Film Forming Nanogels for Needle-free Transdermal Vaccination.

  2022cites this paper
• In Vitro Comparison of Local Nasal Vaccine Delivery and Correlation with Device Spray Performance

  2022cites this paper
• Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection

  2022cites this paper
• Pneumococcal Δpep27 Immunization Attenuates TLRs and NLRP3 Expression and Relieves Murine Ovalbumin-Induced Allergic Rhinitis

  2022cites this paper
• Safety and Immunogenicity of Inactivated Bacillus subtilis Spores as a Heterologous Antibody Booster for COVID-19 Vaccines

  2022cites this paper
• In-Plane Si Microneedles: Fabrication, Characterization, Modeling and Applications

  2022cites this paper
• A Dual Adjuvant System for Intranasal Boosting of Local and Systemic Immunity for Influenza Vaccination

  2022cites this paper
• Microneedles based drug delivery systems: an updated review

  2022cites this paper
• In-Silico Modelling of Transdermal Delivery of Macromolecule Drugs Assisted by a Skin Stretching Hypobaric Device

  2022cites this paper
• A microarray patch SARS-CoV-2 vaccine induces sustained antibody responses and polyfunctional cellular immunity

  2022cites this paper
• Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery

  2022cites this paper
• Induction of Humoral and Cellular Immunity by Intradermal Delivery of SARS-CoV-2 Nucleocapsid Protein Using Dissolvable Microneedles

  2021cites this paper
• Opportunities in an Evolving Pharmaceutical Development Landscape: Product Differentiation of Biopharmaceutical Drug Products

  2021cites this paper
• A Comprehensive Review of Microneedles: Types, Materials, Processes, Characterizations and Applications

  2021cites this paper
• Vaccine delivery alerts innate immune systems for more immunogenic vaccination

  2021cites this paper
• Intranasal immunization with Ag85B peptide 25 displayed on Lactococcus lactis using the PilVax platform induces antigen‐specific B‐ and T‐cell responses

  2021cites this paper
• Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery

  2021cites this paper
• Evaluation of Intranasal Vaccine Delivery Using Anatomical Replicas of Infant Nasal Airways

  2021cites this paper
• Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19

  2021cites this paper
• Use of an automatic needle-free injection device for foot-and-mouth disease vaccination in dairy heifers.

  2021cites this paper
• An Insight of a Needle Free Injector with Magnetic Material

  2020cites this paper
• Advanced trends in protein and peptide drug delivery: a special emphasis on aquasomes and microneedles techniques

  2020cites this paper
• Alternative vaccine delivery methods

  2020cites this paper
• Transport of Artificial Virus-like Nanocarriers (AVN) through intestinal monolayer via Microfold cells

  2020cites this paper
• Assessment of the Immunogenicity of a Novel Live Recombinant Rift Valley Fever arMP-12andDelta;NSm21/384 Vaccine Candidate Following Intranasal Vaccination of Goats, Sheepand Calves in Tanzania

  2020cites this paper
• Intradermal delivery of receptor‐binding domain of SARS‐CoV‐2 spike protein with dissolvable microneedles to induce humoral and cellular responses in mice

  2020cites this paper
• Chitosan nanoparticles as antigen vehicles to induce effective tumor specific T cell responses

  2020cites this paper
• Smart Microneedles with Porous Polymer Layer for Glucose-Responsive Insulin Delivery

  2020cites this paper
• An edible vaccine development for coronavirus disease 2019: the concept

  2020cites this paper
• Microneedles for Transdermal Drug Delivery

  2019cites this paper
• Laterally Dispersing Nozzles for Needle-assisted Jet Injection

  2019cites this paper
• Kinetic stability studies of HBV vaccine in a microneedle patch.

  2019cites this paper
• Transdermal Drug Delivery System

  2019cites this paper
• Microneedle-mediated Vaccine Delivery

  2018cites this paper
• Microneedles-A Potential Transdermal Drug Delivery

  2018cites this paper
• Drying Made Easy : Spray drying a promising technology for the production of stable vaccine and therapeutic protein formulations

  2018cites this paper
• Nebulisation of synthetic lamellar lipids mitigates radiation-induced lung injury in a large animal model

  2018cites this paper
• Noninvasive vaccination against infectious diseases

  2018cites this paper
• Physicochemical study of ascorbic acid 2-glucoside loaded hyaluronic acid dissolving microneedles irradiated by electron beam and gamma ray.

  2018cites this paper
• Transdermal delivery of vitamin K using dissolving microneedles for the prevention of vitamin K deficiency bleeding

  2018cites this paper
• Universal Applicator for Digitally-Controlled Pressing Force and Impact Velocity Insertion of Microneedles into Skin

  2018cites this paper
• Conception d'un patch transdermique intelligent pour le monitoring et l'aide à la prise de médicament

  2018cites this paper
• Biofilm Biology and Vaccine Strategies for Otitis Media Due to Nontypeable Haemophilus influenzae

  2018cites this paper
• Dissolvable layered microneedles with core-shell structures for transdermal drug delivery.

  2018cites this paper
• Safety and Immunogenicity of Rift Valley Fever MP-12 and a Novel arMP-12?NSm21/384 Recombinant Vaccine Candidate in Native Breed of Black Head Sheep (Ovis aries) from Tanzania

  2018cites this paper
• Improving vaccine-related pain, distress or fear in healthy children and adolescents–a systematic search of patient-focused interventions

  2018cites this paper
• Polymeric microneedles for transdermal protein delivery☆

  2018cites this paper
• Dissolving Microneedle Patches for Dermal Vaccination

  2017cites this paper
• Current prospects and future challenges for nasal vaccine delivery

  2017cites this paper
• Design and Analysis of a Continuous Split Typed Needle-Free Injection System for Animal Vaccination

  2017cites this paper
• Technologies to Improve Immunization

  2017cites this paper
• Targeting Photochemical Scalpels or Lancets in the Photodynamic Therapy Field—The Photochemist's Role

  2017cites this paper
• Evaluation of three different administration routes (IM, SC and IN) on humoral immune responses against Mycobacterium Tuberculosis ESAT-6/CFP-10 fusion protein

  2017cites this paper
• An oral microjet vaccination system elicits antibody production in rabbits

  2017cites this paper
• Advances Towards Painless Vaccination and Newer Modes of Vaccine Delivery

  2017influential citation
• A self‐adherent, bullet‐shaped microneedle patch for controlled transdermal delivery of insulin

  2017cites this paper
• Current state and challenges in developing oral vaccines.

  2017cites this paper
• Recombinant biologic products versus nutraceuticals from plants - a regulatory choice?

  2017cites this paper
• Toward jet injection by continuous-wave laser cavitation

  2017cites this paper
• Polymer microneedles fabricated from alginate and hyaluronate for transdermal delivery of insulin.

  2017cites this paper
• Transcutaneous Immunization with a Band-Aid Prevents Experimental Otitis Media in a Polymicrobial Model

  2017cites this paper
• Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics

  2017cites this paper
• Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines

  2016cites this paper
• The success of microneedle-mediated vaccine delivery into skin

  2016cites this paper
• Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge

  2016cites this paper
• Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7

  2016cites this paper
• A Design of Experiment approach to predict product and process parameters for a spray dried influenza vaccine.

  2016cites this paper
• Transdermal Drug Delivery Mediated by Microneedle Arrays: Innovations and Barriers to Success.

  2016cites this paper
• Exploitation of sub-micron cavitation nuclei to enhance ultrasound-mediated transdermal transport and penetration of vaccines.

  2016cites this paper
• Rapidly separating microneedles for transdermal drug delivery.

  2016cites this paper
• Rapid fabrication method of a microneedle mold with controllable needle height and width

  2016cites this paper
• Transcutaneous immunization via rapidly dissolvable microneedles protects against hand-foot-and-mouth disease caused by enterovirus 71.

  2016cites this paper
• Lidocaine carboxymethylcellulose with gelatine co-polymer hydrogel delivery by combined microneedle and ultrasound

  2016cites this paper
• Solid‐in‐oil nanodispersions for transdermal drug delivery systems

  2016cites this paper
• SPECT/CT study of bronchial deposition of inhaled particles

  2016cites this paper
• A microarray MEMS device for biolistic delivery of vaccine and drug powders

  2015cites this paper
• Phase 1 clinical study with Bioneedles, a delivery platform for biopharmaceuticals.

  2015cites this paper
• Divalent toxoids loaded stable chitosan-glucomannan nanoassemblies for efficient systemic, mucosal and cellular immunostimulatory response following oral administration.

  2015cites this paper
• Understanding sharps injuries in home healthcare: The Safe Home Care qualitative methods study to identify pathways for injury prevention

  2015cites this paper
• Skin immunization with influenza vaccines.

  2015cites this paper